m01zh09
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2008 (NCT00679172)
Timeline
Indications
Studied for
Mechanism of action
- Salmonella typhiImmunity, active
Salmonella typhi immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- m01zh09
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04349553 | Phase 1 | Dec 16, 2019 | Prokarium Ltd, Simbec-Orion |
| NCT00679172 | Phase 2 | May 1, 2008 | Emergent BioSolutions |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Emergent BioSolutions | For profit | 1 | 1 | 1 | 2008 |
| Prokarium Ltd | For profit | 1 | 1 | 1 | 2019 |
| Simbec-Orion | For profit | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1